Glenmark Pharmaceuticals Limited (GLENMARK.BO)

INR 1541.0

(1.1%)

Annual Cash Flows

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow -7.65 Billion 6.25 Billion 11.08 Billion 11.31 Billion 13.92 Billion 13.24 Billion
Net Income -18.98 Billion 8.68 Billion 14.41 Billion 13.82 Billion 10.96 Billion 13 Billion
Depreciation & Amortization 5.81 Billion 6.11 Billion 4.86 Billion 4.43 Billion 4.17 Billion 3.25 Billion
Deferred income taxes - -8.79 Billion -7.33 Billion -6.22 Billion -5.9 Billion -5.88 Billion
Stock-based compensation 49.62 Million 67.74 Million 79.16 Million 79.39 Million 30.84 Million 1.07 Million
Change in working capital -7.96 Billion -10.74 Billion -5.61 Billion -3.85 Billion 1.27 Billion 1.36 Billion
Other non-cash items 27.91 Billion 10.92 Billion 4.67 Billion 3.05 Billion 3.39 Billion 1.49 Billion
Investing Cash Flow 45.43 Billion -5.28 Billion -3.33 Billion -6.75 Billion -7.83 Billion -6.98 Billion
Investments in PPE -9.14 Billion -6.07 Billion -7.9 Billion -7.74 Billion -9.31 Billion -12.37 Billion
Acquisitions 54.51 Billion 572.29 Million 15.8 Million 994.33 Million 1.56 Billion 6.21 Billion
Investment purchases -1.29 Million -60.08 Million -400.18 Million -29.08 Million 50.27 Million -150 Million
Sales/Maturities of investments 70.51 Million 50 Million 300 Million 59.05 Million 50 Million 85.55 Million
Other Investing Activities -166.32 Million 230.51 Million 4.65 Billion -29.08 Million -182.02 Million -772.66 Million
Financing Cash Flow -33.89 Billion -774.56 Million -5.2 Billion -4.41 Billion -4.44 Billion -7.38 Billion
Debt repayment -31.68 Billion -5.13 Billion -30.19 Billion -17.1 Billion -8.37 Billion -10.5 Billion
Dividends payments -1.17 Billion -1.36 Billion -926.95 Million -704.47 Million -685.54 Million -678.81 Million
Common Stock Repurchased - - 16.36 Billion - - -318.85 Million
Common Stock Issuance 12 Million - 10.11 Billion - - 4.43 Billion
Other Financing Activities -344.62 Million 5.72 Billion -573.88 Million 13.39 Billion 4.61 Billion -318.85 Million
Accounts receivables 9.69 Billion -8.48 Billion -5.49 Billion -1.17 Billion -2.92 Billion 444.31 Million
Accounts payables -7.34 Billion 1.66 Billion 847.57 Million 1.6 Billion 1.52 Billion 4.49 Billion
Inventory -5.13 Billion -3.75 Billion -2.03 Billion -1.33 Billion 972.56 Million -4.28 Billion
Other working capital -5.18 Billion -167.73 Million 1.06 Billion -2.94 Billion 1.69 Billion 711.44 Million
Cash at beginning of period 14.69 Billion 14.1 Billion 11.38 Billion 11.1 Billion 9.36 Billion 12.33 Billion
Cash at end of period 16.59 Billion 14.43 Billion 14.1 Billion 11.38 Billion 11.1 Billion 9.36 Billion
Capital Expenditure -9.14 Billion -6.07 Billion -7.9 Billion -7.74 Billion -9.31 Billion -12.37 Billion
Effect of forex changes on cash 176.79 Million 123.87 Million 175.5 Million 136.22 Million 97.64 Million -1.83 Billion
Net cash flow / Change in cash 1.89 Billion 325 Million 2.72 Billion 278.2 Million 1.73 Billion -2.97 Billion
Free Cash Flow -16.79 Billion 176.29 Million 3.18 Billion 3.56 Billion 4.61 Billion 870 Million

Cash Flow Charts